Thermo Fisher Scientific Acquires Qiagen

On March 3, Thermo Fisher Scientific Inc. (TMO) and Qiagen N.V. (QGEN) announced that the Board of Directors from both companies approved Thermo Fisher’s proposal to acquire Qiagen. Under the terms of the agreement, Thermo Fisher will pay €39 per share in cash for Qiagen, which values the company at around $11.5 billion. Qiagen is a leading global provider of molecular diagnostics and sample preparation technologies.


Sonal alerted its subscribers about the news event at 2:53 am. Qiagen last traded at 7:25 pm the previous day for $35.80. After the announcement, Qiagen’s stock price spiked above $42 in pre-market trading. The stock price closed for the day at $41.45 with a daily gain of 15.8%.

Find out more about how you can trade on stock merger and acquisition announcements in the Knowledge Center.

To see the latest weekly webinar, you can visit our Live Webinar page.

Subscribe here if you would like to start receiving these signals in real-time and start trading!